Hackensack, NJNCT06747585Now EnrollingIRB Ready

Solid Tumors Clinical Trial in Hackensack, NJ

Access cutting-edge solid tumors treatment through this clinical trial at a research site in Hackensack. Study-provided care at no cost to qualified participants.

Sponsored by Alentis Therapeutics AG

Quick Self-Assessment

See if you qualify for this Hackensack location

Preparing your pre-screening questions...

Expert Care in Hackensack

Access solid tumors specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related solid tumors treatment provided free

Apply for This Hackensack Location

Check if you qualify for this solid tumors clinical trial in Hackensack, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Hackensack

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Hackensack site if eligible
  4. 4Begin participation

About This Solid Tumors Study in Hackensack

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic, pharmacodynamic, preliminary anti-tumor activity, and to determine the recommended Phase II dose (RP2D) of the ALE.P02 monotherapy in adult patients with selected squamous solid tumors.

Sponsor: Alentis Therapeutics AG

Who Can Participate

Inclusion Criteria

Have disease and treatment history as: Have histologically or cytologically confirmed advanced locally recurrent and inoperable or metastatic SqNSCLC, HNSCC (nasopharyngeal cancer included), ESCC or CSCC.
Phase I Dose Escalation: Have received at least one systemic standard of care regimen and being refractory or intolerant to the treatment.
Phase I RDE and Phase II: Have received no more than 2 lines of systemic standard of care regimen and being refractory or intolerant to the treatment.
Have provided tissue for CLDN1 analysis in a central laboratory.
Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group Performance Scale.
Demonstrate adequate bone marrow and organ function.
Patients must have recovered from all toxicities led by prior treatment.
Have measurable disease based on RECIST 1.1 as determined by the site.

Exclusion Criteria

Diagnosed with cancers of predominantly non-squamous histology (eg, adenosquamous car

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Hackensack?

Yes, this clinical trial (NCT06747585) has an active research site in Hackensack, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Solid Tumors Treatment Options in Hackensack, NJ

If you're searching for solid tumors treatment options in Hackensack, NJ, this clinical trial (NCT06747585) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Hackensack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all solid tumors clinical trials near you to find additional studies recruiting in your area.

More Advanced Solid Tumors Trials in Hackensack, NJ

See all advanced solid tumors clinical trials recruiting in Hackensack — not just this study.

Browse Advanced Solid Tumors Trials in Hackensack →

Browse More Trials by Condition

Advanced Solid Tumors TrialsAll Conditions →

Ready to Join in Hackensack?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Hackensack, NJ